semaglutide 2.4 mg obesity Semiglutide (Wegovy) in Overweight Non-Diabetic Heart Patients Slashes the Risk of Death!: Joel Kahn, MD: Integrative Cardiologist ECO 2026 - Gastrointestinal Tolerability

Rather than treating labs as a checkbox or an optional add-on, Meto built its entire GLP-1 pathway around a single, purpose-designed metabolic panel that consolidates every guideline-recommended biomarker CMP, HbA1c, full lipid panel, TSH, CBC, eGFR, ALT/AST, fasting insulin, and hs-CRP into one blood draw

Poor sleep can reduce some of the benefits of GLP-1

Pedunculated fibroids are mushroom-shaped fibroids with a stalk/stem attached to the uterine wall

GLP-1 and GIP-based therapies are transforming the management of overweight and obesity, impacting clinical practice, patient conversations, and policy decisions